Ricardo Graña-Montes

Ricardo Graña-Montes

Auto-generated profile, based on publicly available information

Ricardo Graña-Montes

Universidad San Ignacio de Loyola - USIL

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2011
Verified
Book Chapter
Closed access
PDF file
Natalia Sanchez de GrootNatalia Sanchez de Groot
Natalia Sanchez de Groot
VCVirginia Castillo
Virginia Castillo
RGRicardo Graña-Montes
Ricardo Graña-Montes
Salvador VenturaSalvador Ventura
Salvador Ventura

29 April 2011 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
VCVirginia Castillo
Virginia Castillo
RGRicardo Graña‐Montes
Ricardo Graña‐Montes
RSRaimon Sabate
Raimon Sabate
Salvador VenturaSalvador Ventura
Salvador Ventura

6 March 2014 in Biomacromolecules
Verified
Journal Article
Closed access
RGRicardo Graña-Montes
Ricardo Graña-Montes
PMPatrizia Marinelli
Patrizia Marinelli
DRDavid Reverter
David Reverter
Salvador VenturaSalvador Ventura
Salvador Ventura

1 October 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RSRicardo Sant'ANna
Ricardo Sant'ANna
CBCarolina Braga
Carolina Braga
NVNathalia Varejão
Nathalia Varejão
KPKarinne M. Pimenta
Karinne M. Pimenta
RGRicardo Graña-Montes
Ricardo Graña-Montes
DFDebora Foguel
Debora Foguel
Protein aggregation into β-sheet-enriched amyloid fibrils is associated with an increasing number of human disorders. The adoption of such amyloid conformations seems to constitute a generic property of polypeptide chains. Therefore, during evolution, proteins have adopted negative design strategies to diminish their intrinsic propensity to aggregate, including enrichment of gatekeeper charged residues at the flanks of hydrophobic aggregation-prone segments. Wild type transthyretin (TTR) is responsible for senile systemic amyloidosis, and more than 100 mutations in the TTR gene are involved in familial amyloid polyneuropathy. The TTR 26–57 segment bears many of these aggressive amyloidogenic mutations as well as the binding site for heparin. We demonstrate here that Lys-35 acts as a gatekeeper residue in TTR, strongly decreasing its amyloidogenic potential. This protective effect is sequence-specific because Lys-48 does not affect TTR aggregation. Lys-35 is part of the TTR basic heparin-binding motif. This glycosaminoglycan blocks the protective effect of Lys-35, probably by neutralization of its side chain positive charge. A K35L mutation emulates this effect and results in the rapid self-assembly of the TTR 26–57 region into amyloid fibrils. This mutation does not affect the tetrameric protein stability, but it strongly increases its aggregation propensity. Overall, we illustrate how TTR is yet another amyloidogenic protein exploiting negative design to prevent its massive aggregation, and we show how blockage of conserved protective features by endogenous factors or mutations might result in increased disease susceptibility.

25 May 2012 in Biomacromolecules
Verified
Journal Article
Closed access
RSRaimon Sabate
Raimon Sabate
AEAlba Espargaró
Alba Espargaró
RGRicardo Graña-Montes
Ricardo Graña-Montes
DRDavid Reverter
David Reverter
Salvador VenturaSalvador Ventura
Salvador Ventura

1 April 2018 in Redox Biology
Verified
Journal Article
Open access
PMPatrizia Marinelli
Patrizia Marinelli
SNSusanna Navarro
Susanna Navarro
RGRicardo Graña-Montes
Ricardo Graña-Montes
MBManuel Bañó-Polo
Manuel Bañó-Polo
MFMaría Rosario Fernández
María Rosario Fernández
Salvador VenturaSalvador Ventura
Salvador Ventura
Oxidatively modified forms of proteins accumulate during aging. Oxidized protein conformers might act as intermediates in the formation of amyloids in age-related disorders. However, it is not known whether this amyloidogenic conversion requires an extensive protein oxidative damage or it can be promoted just by a discrete, localized post-translational modification of certain residues. Here, we demonstrate that the irreversible oxidation of a single free Cys suffices to severely perturb the folding energy landscape of a stable globular protein, compromise its kinetic stability, and lead to the formation of amyloids under physiological conditions. Experiments and simulations converge to indicate that this specific oxidation-promoted protein aggregation requires only local unfolding. Indeed, a large scale analysis indicates that many cellular proteins are at risk of undergoing this kind of deleterious transition; explaining how oxidative stress can impact cell proteostasis and subsequently lead to the onset of pathological states.